Skip to content

A Study to Compare individualised Homoeopathic Treatment and Ferrum Phosphoricum in Women with Anaemia using Repertoy

A RANDOMISED PARALLEL ARM DOUBLE BLIND CONTROLLED TRIAL COMPARING THE EFFECTIVENESS OF INDIVIDUALISED HOMOEOPATHIC TREATMENT SELECTED THROUGH COMPLETE REPERTORY WITH FERRUM PHOSPHORICUM 6C IN ANEMIC FEMALES ASSESSED WITH HAEMOGLOBIN LEVELS. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101785
Enrollment
75
Registered
2026-01-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D539- Nutritional anemia, unspecified

Interventions

Intervention1: INDIVIDUALISED HOMOEOPATHIC MEDICINE: 1 DOSE 5 PILLS ORALLY ON EMPTY STOMACH AT BASELINE FOLLOWED BY REPEITITION OF DOSE BASED ON SUSCEPTIBILITY Control Intervention1: FERRUM PHOS 6C: 1

Sponsors

JIMS HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female patients of age group 18yrs to 55yrs who are diagnosed with anemia with haemoglobin value between 7 gm dL 11 gm dL less than 11 gm dl but not less than 7 gm dl

Exclusion criteria

Exclusion criteria: Patients with Other blood disorders like Thalassemia sickle cell anemia are excluded by CBP and Peripheral blood smear and those who are in need of any emergency interventions and are having history of serious systemic illness and also Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Expected to rule out the utility of the complete repertory in selection of individualised homoeopathic treatment in comparison with Ferrum phos 6C in anemic females assessed using changes in haemoglobin levels at baseline 3rd month and the end of 6 months treatment periodTimepoint: Expected to rule out the utility of the complete repertory in selection of individualised homoeopathic treatment in comparison with Ferrum phos 6C in anemic females assessed using changes in haemoglobin levels at baseline 3rd month and the end of 6 months treatment period

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDRKUNAPAREDDY PRATHYUSHA

JIMS HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL

drvishalvd@gmail.com9422638599

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026